| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
40,080,000 |
| Market
Cap: |
16.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4002 - $0.4002 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases. Co.'s business segments are: Specialized BioTherapeutics, which is developing and moving toward potential commercialization of HyBryte™, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma; and Public Health Solutions, which includes development programs for RiVax®, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic resistant and other infectious disease and its vaccine programs targeting filoviruses and CiVax™, its vaccine candidate for the prevention of COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Brughera Marco Maria |
Director |
– • – |
2016-12-16 |
4 |
B |
$3.16 |
$6,320 |
D/D |
2,000 |
2,750 |
2.39 |
- |
|
| Krumeich Karen R |
SVP and CFOOfficer |
• – – |
2016-06-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,000 |
|
- |
|
| Zeldis Jerome B |
Director |
– • – |
2015-12-23 |
4 |
B |
$1.27 |
$3,175 |
D/D |
2,500 |
69,166 |
2.31 |
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2015-12-22 |
4 |
B |
$1.29 |
$12,878 |
D/D |
10,000 |
85,761 |
2.81 |
- |
|
| Lapointe Gregg Anthony |
Director |
– • – |
2015-08-31 |
4 |
OE |
$0.30 |
$7,500 |
D/D |
25,000 |
73,781 |
|
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2015-07-01 |
4 |
OE |
$0.61 |
$4,357 |
D/D |
7,143 |
82,904 |
|
- |
|
| Zeldis Jerome B |
Director |
– • – |
2015-04-09 |
4 |
OE |
$0.61 |
$10,893 |
D/D |
17,857 |
66,666 |
|
- |
|
| Brownlie Keith L |
Director |
– • – |
2015-04-09 |
4 |
OE |
$0.61 |
$8,714 |
D/D |
14,286 |
50,000 |
|
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2014-12-22 |
4 |
B |
$1.21 |
$10,001 |
D/D |
8,265 |
75,761 |
2.81 |
- |
|
| Warusz Joseph Michael |
VP of Finance/Acting CFO |
• – – |
2014-12-22 |
4 |
B |
$1.21 |
$10,001 |
D/D |
8,265 |
12,955 |
2.74 |
- |
|
| Brughera Marco Maria |
Director |
– • – |
2014-08-05 |
4 |
OE |
$2.01 |
$15,075 |
D/D |
7,500 |
7,500 |
|
- |
|
| Warusz Joseph Michael |
VP of Admin, Controller / PAO |
• – – |
2014-05-19 |
4 |
OE |
$0.64 |
$3,002 |
D/D |
4,690 |
4,690 |
|
- |
|
| Brownlie Keith L |
Director |
– • – |
2014-05-14 |
4 |
OE |
$0.30 |
$5,000 |
D/D |
16,667 |
35,714 |
|
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2014-05-13 |
4 |
OE |
$0.64 |
$5,002 |
D/D |
7,815 |
67,496 |
|
- |
|
| Zeldis Jerome B |
Director |
– • – |
2013-06-25 |
4 |
B |
$1.05 |
$24,999 |
D/D |
23,809 |
48,809 |
2.39 |
- |
|
| Brownlie Keith L |
Director |
– • – |
2013-06-25 |
4 |
B |
$1.05 |
$19,999 |
D/D |
19,047 |
19,047 |
2.39 |
- |
|
| Schaber Christopher |
Chairman, CEO and President |
• • – |
2013-06-25 |
4 |
B |
$1.05 |
$9,999 |
D/D |
9,523 |
59,681 |
2.81 |
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2013-06-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,367,816 |
|
- |
|
| Zeldis Jerome B |
Director |
– • – |
2013-06-20 |
4 |
OE |
$0.30 |
$7,500 |
D/D |
25,000 |
25,000 |
|
- |
|
| Schaber Christopher |
Chairman CEO and President |
• • – |
2012-04-10 |
4 |
B |
$0.51 |
$5,047 |
D/D |
9,900 |
50,157 |
2.81 |
- |
|
| Schaber Christopher |
Chairman CEO and President |
• • – |
2012-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
333,333 |
805,150 |
|
- |
|
| Mintz Hal |
10% Owner |
– – • |
2010-08-18 |
4 |
S |
$0.24 |
$46,155 |
I/I |
(192,314) |
21,573,778 |
|
- |
|
| Mintz Hal |
10% Owner |
– – • |
2010-08-18 |
4 |
S |
$0.24 |
$38,400 |
I/I |
(160,000) |
21,766,092 |
|
- |
|
| Mintz Hal |
10% Owner |
– – • |
2010-08-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,606,092 |
|
- |
|
| Cavazza Claudio |
10% Owner |
– – • |
2010-06-18 |
4 |
B |
$0.21 |
$1,764,759 |
I/I |
8,608,580 |
54,227,816 |
1.5 |
- |
|
92 Records found
|
|
Page 2 of 4 |
|
|
